Huntington National Bank Ligand Pharmaceuticals Inc Transaction History

Huntington National Bank

$13.5 Billion
Q3 2024

A detailed history of Huntington National Bank transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Huntington National Bank holds 42 shares of LGND stock, worth $4,643. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 42 -0.0%

Holding current value

$4,643

Previous $3,000 33.33%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$68.53 - $87.91 $205 - $263	3 Added 7.69%	42 $3,000
Q4 2023 Feb 07, 2024	BUY	$49.57 - $72.63 $1,883 - $2,759	38 Added 3800.0%	39 $2,000
Q3 2023 Nov 08, 2023	SELL	$58.86 - $72.67 $706 - $872	-12 Reduced 92.31%	1 $0
Q2 2023 Aug 11, 2023	BUY	$69.53 - $79.33 $834 - $951	12 Added 1200.0%	13 $0
Q4 2021 Jan 21, 2022	BUY	$127.69 - $165.85 $127 - $165	1 New	1 $0
Q4 2020 Jan 11, 2021	SELL	$80.55 - $106.05 $19,654 - $25,876	-244 Closed	0 $0
Q3 2020 Oct 30, 2020	BUY	$89.56 - $126.72 $447 - $633	5 Added 2.09%	244 $23,000
Q2 2020 Jul 30, 2020	BUY	$68.28 - $123.65 $6,418 - $11,623	94 Added 64.83%	239 $27,000
Q1 2020 Apr 27, 2020	SELL	$63.37 - $107.88 $4,182 - $7,120	-66 Reduced 31.28%	145 $11,000
Q4 2019 Jan 17, 2020	SELL	$96.94 - $113.59 $2,908 - $3,407	-30 Reduced 12.45%	211 $22,000
Q3 2019 Nov 01, 2019	SELL	$86.25 - $120.16 $3,967 - $5,527	-46 Reduced 16.03%	241 $24,000
Q2 2019 Jul 23, 2019	BUY	$107.38 - $129.34 $3,543 - $4,268	33 Added 12.99%	287 $33,000
Q1 2019 Apr 09, 2019	BUY	$105.93 - $142.47 $5,508 - $7,408	52 Added 25.74%	254 $32,000
Q4 2018 Jan 28, 2019	BUY	$128.36 - $272.13 $770 - $1,632	6 Added 3.06%	202 $27,000
Q3 2018 Oct 18, 2018	SELL	$211.18 - $274.49 $3,167 - $4,117	-15 Reduced 7.11%	196 $54,000
Q2 2018 Jul 19, 2018	SELL	$150.77 - $207.98 $9,800 - $13,518	-65 Reduced 23.55%	211 $44,000
Q1 2018 Apr 30, 2018	SELL	$138.63 - $182.62 $14,833 - $19,540	-107 Reduced 27.94%	276 $46,000
Q3 2017 Oct 24, 2017	BUY	$120.91 - $137.94 $46,308 - $52,831	383	383 $52,000

Others Institutions Holding LGND

# of Institutions

255

Shares Held

18.1M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.87B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.

Account

Huntington National Bank Ligand Pharmaceuticals Inc Transaction History